Drug Approval | August 24, 2023
Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
The company has reported total income of Rs. 2481 crores during the period ended December 31, 2022
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
Proposed amalgamation now awaits NCLT approval; shareholders to receive 51 Torrent Pharma shares for every 100 JB Pharma shares held
Analysts expect modest revenue growth but pressure on profitability in the March quarter
Ind-Ra expects chronic therapies to outpace IPM as compliance improves and lifestyle diseases rise
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
